Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2012; 18(1): 55-63
Published online Jan 7, 2012. doi: 10.3748/wjg.v18.i1.55
Published online Jan 7, 2012. doi: 10.3748/wjg.v18.i1.55
Table 6 Summary of some reports on the efficacy and rejection rate following the use of interferon alone or in combination with ribavirin in post renal transplant hepatitis C virus infection
Ref. | Yr | No. of patientstreated | Anti HCV therapy used(No. of patients) | Immunosuppression used(% of patients) | ETR (%) | SVR (%) | Rate of allograftrejection/failure (%) |
Ozgur et al[32] | 1995 | 5 | CI alone (5) | CNI (100) | NR | NR | 40 |
Aza (100) | |||||||
S (100) | |||||||
Rosting et al[31] | 19951 | 14 | CI alone (14) | CNI (85.7) | 28.60 | 0 | 35.70 |
Aza (50) | |||||||
S (85.7) | |||||||
Hanafusa et al[14] | 1998 | 10 | CI alone (10) | CNI (NS) | 10 | 0 | 40 |
Aza (100) | |||||||
S (100) | |||||||
Baid et al[27] | 20032 | 12 | CI + R (11) | CNI (100) | NS | 33 | 17 |
CI alone (1) | Aza (17) | ||||||
C (67) | |||||||
S (100) | |||||||
Sharma et al[26] | 20063 | 6 | CI + R (5) | CNI (100) | 66.60 | 33.30 | 66.60 |
PEG-INF + R (1) | Aza (50) | ||||||
C (14) | |||||||
S (100) | |||||||
Pageaux et al[67] | 2009 | 8 | PEG-INF + R (4) | CNI (75) | 75 | 50 | 0 |
PEG-INF alone (4) | Aza (37.5) | ||||||
C (25) | |||||||
S (100) | |||||||
Aljumah et al | Current study | 19 | PEG-INF + R (19) | CNI (89.5) | 47.40 | 42.10 | 5.30 |
C (78.9) | |||||||
S (100) |
- Citation: Aljumah AA, Saeed MA, Al Flaiw AI, Al Traif IH, Al Alwan AM, Al Qurashi SH, Al Ghamdi GA, Al Hejaili FF, Al Balwi MA, Al Sayyari AA. Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients. World J Gastroenterol 2012; 18(1): 55-63
- URL: https://www.wjgnet.com/1007-9327/full/v18/i1/55.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i1.55